News und Analysen
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
EQS-News: Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site
EQS-News: Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site
MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary
MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Relief Therapeutics Announces Executive Leadership Team Change
Relief Therapeutics Announces Executive Leadership Team Change
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
EQS-News: Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
EQS-News: Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
MD Medical Group Investments Plc: MD Medical Group Annual report 2022
MD Medical Group Investments Plc: MD Medical Group Annual report 2022
MD Medical Group Investments Plc: MD Medical Group maintains strong EBITDA margin
MD Medical Group Investments Plc: MD Medical Group maintains strong EBITDA margin
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023